Project Grant R61AG088891
Award Date
8/1/24
Completion Date
7/31/25
Dollars Obligated
$331K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
This $1,933,556 Project Grant awarded by the National Institute on Aging (NIA) under its Aging Research program (CFDA 93.866) will support research to assess the impact of hospital-based health information technology (hospital-HIT) on healthcare quality and equity for patients with Alzheimer's disease and related dementias (ADRD). The primary awardee, the University of Maryland, College Park, will conduct a ten-year longitudinal study to evaluate how hospital-HIT systems that promote care...
The National Institute on Aging (NIA) awarded a $2,124,788 Project Grant (CFDA 93.866 - Aging Research) to The Washington University in St. Louis to study the impact of the new Accountable Care Organization Realizing Equity, Access, and Community Health (ACO REACH) program on outcomes and equity for Medicare beneficiaries with Alzheimer's disease and related dementias (AD/ADRD). This 4-year grant, with a period of performance from Aug 15, 2024 to Apr 30, 2028, will utilize innovative analyses of...
This $322,286 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a study by The Johns Hopkins University to advance health equity in the use of novel treatments for Alzheimer's disease and related dementias (ADRD). The study will have two phases. In the planning phase (R61), the researchers will conduct focus groups with diverse individuals affected by ADRD to understand their medication decision-making processes. They will then design discrete...
This $169,560 Project Grant was awarded by the National Institute on Aging under the Aging Research (CFDA 93.866) program to the Regents of the University of Michigan. The grant will fund research to identify disruptions in inhibitory interneurons that contribute to neural network dysfunction in Alzheimer's disease (AD) and related dementias. Key objectives include cataloging mediators of interneuron dysfunction, developing strategies to reverse this pathology, and evaluating the impact of...
The National Institute on Aging (NIA) awarded a $3,374,303 Project Grant under the Aging Research Federal Grant Program (CFDA 93.866) to Weill Medical College of Cornell University to conduct the "Understanding Ambulatory Care Utilization in Alzheimer's Disease and Related Dementias (ACUA)" study. The project aims to examine the role of fragmented ambulatory care in the diagnosis and treatment of people living with dementia, including potential impacts on medication management,...
The National Institute on Aging (NIA) awarded a $2,169,736 Project Grant under the Aging Research federal grant program (CFDA 93.866) to the University of Florida. The grant, titled "ISMART: Intelligent Social Risk Management in AD/ADRD Patients," aims to develop a machine learning-based social risk management platform that can be integrated into electronic health record systems to improve the quality of care and quality of life for people living with Alzheimer's disease and related...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,559,999 to the Regents of the University of Michigan to conduct a comprehensive study on the APOE gene and the noncoding RNA AANCR to advance Alzheimer's disease treatment. The research aims to elucidate how AANCR regulates APOE transcription and how AANCR is modulated to maintain cell-type specific and stress-induced APOE expression. The project will also assess the effects of APOE...
This $287,118 Project Grant was awarded on September 1, 2023 by the National Institute on Aging (NIA) under the Aging Research (CFDA 93.866) grant program. The grant will fund the development of techniques to use deep transfer learning and multimodal data, including brain MRIs, genetic information, and cognitive tests, to enable the early detection and forecasting of Alzheimer's disease progression. The University of Massachusetts (UMass), as the prime awardee, will create an end-to-end...
The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), has awarded a $299,553 Project Grant to Pilltrax Systems LLC to develop an enhanced medication management service for providers caring for African American and Latino older adults at risk of Alzheimer's disease and related dementias (ADRD). The proposed solution will comprise an electronic pill dispenser that sends medication adherence notifications, an adherence assessment tool, and a provider...
The University of Alabama at Birmingham (UAB) was awarded a $297,000 Project Grant from the National Institute on Aging under the Aging Research federal grant program (CFDA 93.866) to conduct a mixed methods study examining access, costs, and benefits of new Alzheimer's disease drugs for African American and white patients in Alabama. The key objectives of this 1-year planning phase (R61) and 4-year study (R33) are to: 1) qualitatively analyze challenges to accessing new Alzheimer's drugs,...